Document is current
Any future updates will be listed below
-
Authors
Raventós, Aida https://orcid.org/0009-0002-1910-3651
Arias-Salgado, Elena G.
Pérez, Alba
Alvarez-Román, María Teresa
Butta, Nora V.
Monzon Manzano, Elena
Acuña, Paula
Jiménez-Yuste, Víctor
Costa, Montserrat
Bravo, María Isabel
-
Funding
Funding for this research was provided by:
Grifols
- License Information
-
More Information
Article History
Received: 1 August 2024
Accepted: 22 November 2024
First Online: 21 December 2024
Declarations
:
: Aida Raventós, Alba Pérez, Montserrat Costa and María-Isabel Bravo are full-time employees of Grifols and have no other competing interests to declare. Víctor Jiménez-Yuste received reimbursement for attending symposia/congresses and/or honoraria for speaking and/or honoraria for consulting, and/or funds for research from Shire, Bayer, CSL-Behring, Grifols, Novo Nordisk, Sobi, Octapharma, BioMarin, Sanofi and Pfizer. María Teresa Álvarez-Román received reimbursement for attending symposia and/or honoraria for speaking and/or honoraria for consulting, and/or funds for research from Takeda, Bayer, CSL-Behring, Grifols, Novo Nordisk, Sobi, Octapharma, BioMarin, Novartis, Amgen and Pfizer. Elena G. Arias-Salgado received reimbursement for attending symposia/congresses and/or honoraria for speaking, and/or funds for research from Bayer, CSL-Behring, Grifols, Novartis and Novo Nordisk. Nora V. Butta received reimbursement for attending symposia/congresses and/or honoraria for speaking, and/or funds for research from Pfizer, Amgen, CSL-Behring, Grifols, Novartis and Novo Nordisk. Elena Monzón Manzano and Paula Acuña received reimbursement for attending symposia/congresses from Takeda, Novartis and Novo Nordisk.
: The ethical approval to report this study was obtained from the ethics committee of Hospital Universitario la Paz, Madrid, Spain (ID number: HULP PI-4320), before the study was initiated.
: Not applicable.
